Indefinite Delivery Contract 36C24421D0058

Award Date 3/15/21
Last Date to Order 3/14/23
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) awarded a single award indefinite delivery contract to Nuclear Diagnostic Products, Inc. to provide general radiopharmaceuticals. Under the contract, two firm fixed price delivery orders were issued for approximately $1.9 million and $2.2 million respectively to supply radiopharmaceutical products to VA medical centers in New York and New Jersey. The delivery orders have a...
The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Nuclear Diagnostic Products, Inc., a for-profit radiopharmaceutical supplier, to provide general radiopharmaceuticals to support nuclear medicine imaging procedures for the VA's Veterans Integrated Service Network (VISN) 2 healthcare system. The $4,038,178.15 IDC, which does not have a set-aside designation, has a period of performance through February 2026. Multiple firm fixed-price delivery orders...
The Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 16 (VISN 16) has awarded an Indefinite Delivery Contract (IDC) to Numedrx Pharmacy Solutions LLC, a self-certified small disadvantaged business, to provide radiopharmaceutical supplies. This $2,692,693.25 single-award IDC, with a period of performance through September 2025, allows VISN 16 to issue firm fixed price delivery orders as needed to procure critical radiopharmaceutical products...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded an indefinite delivery contract to Medi-Physics, Inc. to provide radiopharmaceuticals in support of nuclear medicine services. No set-aside provisions were applied. The contract includes a potential value of $633,955.36 over its period of performance from March 1, 2020 through February 28, 2023. Delivery orders issued against the contract include $214,344.50 awarded on March 1, 2022...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded an indefinite delivery contract to Pharmalogic WV LTD for the delivery of radiopharmaceutical products and services in support of nuclear medicine programs serving veterans. The base contract value is $388,738.36 for the period of October 1, 2020 through March 31, 2024. Four task orders were subsequently issued against the contract with values ranging from $265,884.10 to $900,000.00...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded an indefinite-delivery contract to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, to provide single dose radiopharmaceuticals in support of nuclear medicine services. Over the period of performance from March 2020 to February 2025, the contract established a total potential value of $2,664,954.52. Delivery orders issued against this contract vehicle from 2020...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single award indefinite delivery contract to Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, with a potential value of $866,632.41 to provide radio pharmaceuticals. Under this contract, two firm fixed price delivery orders have been awarded to date for a total of $441,612.06 to supply radiopharmaceutical products through January 2023...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single award indefinite delivery contract to Panhandle Nuclear RX, LTD. of Amarillo, Texas. The contract has a potential value of $615,206 and a period of performance through January 3, 2025. Under the contract, Panhandle Nuclear RX will provide radiopharmaceutical products to support diagnostic imaging services across VISN 17's healthcare system. Two firm fixed price delivery...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Trillamed LLC for positron emission tomography radiopharmaceuticals. The single award contract has a potential value of $1.5 million and period of performance through September 2027. Task orders issued to date include $212,629 firm fixed price delivery orders for fiscal years 2023 and 2024 for supply of radiopharmaceuticals from Trillamed's Bingham...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award, indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, with a potential value of $420,000. The contract establishes Jubilant Radiopharma as the supplier of nuclear medicine radiopharmaceuticals to support VA healthcare programs in the Norcross, Georgia area over a five-year period of performance from December...
  • 36C24421D0058
    Indefinite Delivery Contract
  • 5
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a single award indefinite delivery contract to Nuclear Diagnostic Products, Inc. to provide radiopharmaceuticals. Under the contract, three firm fixed price delivery orders were issued for a combined value of $1,142,529.63 to supply products to VA medical facilities in New Jersey, Pennsylvania and Delaware through March 2026.

The original solicitation sought radiopharmaceuticals to support nuclear medicine imaging procedures. Delivery orders have provided radiopharmaceuticals from Nuclear Diagnostic Products' facilities in Philadelphia, Pennsylvania, Lebanon, Pennsylvania and Cherry Hill, New Jersey. As the integrated healthcare network for veterans in the region, VISN 4 utilizes radiopharmaceuticals in diagnostic scans and imaging modalities like positron emission tomography and single-photon emission computed tomography to evaluate and treat medical conditions.

No set-asides were applied to the contract or associated orders. The indefinite delivery contract establishes Nuclear Diagnostic Products as a prime vendor for radiopharmaceuticals through March 2023, with $342,741.33, $512,979.57 and $285,808.53 in firm fixed price orders awarded from March 2021 through March 2023 to supply the specialized pharmaceuticals.

Generated 1/5/24, 1:05 AM